John McKune's Net Worth

$577 Thousand

Estimate Recalculated Nov 1, 2024 05:03AM EST

Who is John McKune?

John McKune does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Carbylan Therapeutics, Inc., and Pulmonx Corp.

SEC CIK

John McKune's CIK is 0001650427

Past Insider Trading and Trends

2024 was John McKune's most active year for acquiring shares with 4 total transactions. John McKune's most active month to acquire stocks was the month of February. 2023 was John McKune's most active year for disposing of shares, totalling 3 transactions. John McKune's most active month to dispose stocks was the month of February. 2015 saw John McKune paying a total of $0.00 for 50,000 shares, this is the most they've acquired in one year. In 2024 John McKune cashed out on 1,078 shares for a total of $9,766.68, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Carbylan Therapeutics, Inc. (KALV) Snapshot price: $12.34

See Remarks

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 4
Form 4
—
0
—
—
0
Nov 2
Form 3
—
0
—
—
0
No matching records found

Pulmonx Corp (LUNG) Snapshot price: $7.31

INTERIM CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
+60.75%
28.8K
—
—
76.21K
Mar 1
Form 4
+27.47%
13.32K
$9.06
-$9,766.68
61.81K
Mar 1
Form 4
+15.21%
6.29K
$10.34
-$9,738.93
47.65K
Dec 1
Form 3
—
0
—
—
0
No matching records found